August 2024 FDA Recall Drug by Taro Pharmaceuticals U.s.a., Inc.
D-0633-2024 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on August 7, 2024 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed in Product was distributed to one distributor and the recall is currently completed.

Recall Number: D-0633-2024

Reason for Recall
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Initiated
08-07-2024
Reported
08-21-2024
Quantity
96 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Taro Pharmaceuticals U.S.A., Inc.
Product was distributed to one distributor
Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01

Batch or Lot Expiration Information

Lot# AD12890, Exp 09/30/2024